Journal of Religion and Health

, Volume 17, Issue 2, pp 117–126 | Cite as

Mystical and archetypal experiences of terminal patients in DPT-assisted psychotherapy

  • William A. Richards


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Grof, S.,Realms of the Human Unconscious: Observations from LSD Research. New York, Viking Press, 1975.Google Scholar
  2. 2.
    Pahnke, W. N., and Richards, W. A., “Implications of LSD and Experimental Mysticism,”J. Religion and Health, 1966,5, 175–208.Google Scholar
  3. 3.
    Bucke, R. M.,Cosmic Consciousness. Philadelphia, Innes & Sons, 1901.Google Scholar
  4. 4.
    James, W.,The Varieties of Religious Experience. New York, Modern Library, 1902.Google Scholar
  5. 5.
    Pratt, J. B.,The Religious Consciousness. New York, Macmillan, 1921.Google Scholar
  6. 6.
    Suzuki, D. T.,Zen Buddhism: Selected Writings of D.T. Suzuki. W. Barrett, ed., Garden City, New York. Doubleday, 1956.Google Scholar
  7. 7.
    Clark, W. H.,The Psychology of Religion. New York, Macmillan, 1958.Google Scholar
  8. 8.
    Stace, W. T.,Mysticism and Philosophy. Philadelphia, J. B. Lippincott, 1960.Google Scholar
  9. 9.
    Maslow, A. H.,Religions, Values and Peak Experiences. Columbus, Ohio State University Press, 1964.Google Scholar
  10. 10.
    James,op. cit., p. 371.Google Scholar
  11. 11.
    Otto, R.,The Idea of the Holy, J. W. Harvey, trans. New York, Galaxy Books (1923), 1958.Google Scholar
  12. 12.
    Jung, C. G.,The Archetypes and the Collective Unconscious. R. F. C. Hull, trans.Collected Works, 9, 1 New York, Pantheon, 1959, p. 5. —Aion: Researches into the Phenomenology of the Self. R. F. C. Hull, trans.Collected Works, 9, 2. New York, Pantheon, 1959, p. 20.Google Scholar
  13. 13.
    See Campbell, J.,The Hero with a Thousand Faces. New York, Pantheon, 1949.Google Scholar
  14. 14.
    Grof,op. cit.,. p. 32.Google Scholar
  15. 15.
    DiMascio, A., and Klerman, G. L., “Experimental Human Psychopharmacology: The Role of Non-Drug Factors” In Sarwer-Foner, G. J. ed.,The Dynamics of Psychiatric Drug Therapy. Springfied, Illinois, Charles C. Thomas, 1960, pp. 56–97.Google Scholar
  16. 16.
    Shostrom, E. L., “A Test for the Measurement of Self-Actualization,”Educational and Psychological Measurement, 1965,24, 207–218.Google Scholar
  17. 17.
    Faillace, L. A.; Vourlekis, A.; and Szara, S., “Clinical Evaluation of Some Hallucinogenic Tryptamine Derivatives,”J. Nervous and Mental Diseases, 1967;145, 306–313, Soskin, R. A.; Grof; and Richards, “Low Doses of Dipropyltryptamine in Psychotherapy,”Arch. Gen. Psychiatry, 1973,28, 817–821.Google Scholar
  18. 18.
    Richards; Grof; Goodman, L. E.; and Kurland, A. A., “LSD-Assisted Psychotherapy and the Human Encounter with Death,”J. Transpersonal Psychology, 1972,4, 121–150.Google Scholar
  19. 19.
    Pahnke, “Drugs and Mysticism An Analysis of the Relationship between Psychedelic Drugs and the Mystical Consciousness.” Unpublished Ph.D. dissertation, Cambridge, Harvard University, 1963.Google Scholar
  20. 20.
    Smith, H., “Do Drugs Have Religious Import?”J. Philosophy, 1964,61, 517–530.Google Scholar

Copyright information

© Institutes of Religion and Health 1978

Authors and Affiliations

  • William A. Richards
    • 1
    • 2
  1. 1.Department of PsychiatryUniversity of Maryland School of MedicineBaltimore
  2. 2.Antioch CollegeColumbia

Personalised recommendations